"Loyalty trials" are common to a range of conflict settings, with consequences that range from harassment to imprisonment, torture, or death. Yet, they have received little if any attention as a general phenomenon in studies of state repression, civil war, or rebel governance, which focus on particular behaviors that authorities use to put people on trial, such as dissent, defection, and resistance. Using a computational model and data on the German Democratic Republic and the Occupied Palestinian Territories, we focus on the dynamics of "loyalty trials" held to identify enemy collaborators-the interaction between expectations, perceptions, and behavior. We use our framework to explore the conditions under which trials result in widespread defection, as in the German Democratic Republic, or in conformity as illustrated by our study of the Occupied Palestinian Territories. The polarizing nature of loyalty trials and the propensity to over- or under-identify threats to political order have notable implications for democratic and non-democratic societies alike.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11581917 | PMC |
http://dx.doi.org/10.1177/00220027231222004 | DOI Listing |
J Conflict Resolut
January 2025
Department of International Relations and Political Science, Graduate Institute of International and Development Studies, Geneva, Switzerland.
"Loyalty trials" are common to a range of conflict settings, with consequences that range from harassment to imprisonment, torture, or death. Yet, they have received little if any attention as a general phenomenon in studies of state repression, civil war, or rebel governance, which focus on particular behaviors that authorities use to put people on trial, such as dissent, defection, and resistance. Using a computational model and data on the German Democratic Republic and the Occupied Palestinian Territories, we focus on the dynamics of "loyalty trials" held to identify enemy collaborators-the interaction between expectations, perceptions, and behavior.
View Article and Find Full Text PDFBr J Nutr
November 2024
Amsterdam UMC location Vrije Universiteit Amsterdam, Epidemiology and Data Science, De Boelelaan 1117, Amsterdam, the Netherlands.
CNS Drugs
November 2024
Chief Medical Officer and Senior Vice President of Research and Development, Supernus Pharmaceuticals, Inc, 9715 Key West Avenue, Rockville, MD, USA.
Background And Objective: Viloxazine ER (extended-release capsules; Qelbree) is a nonstimulant medication that has been approved by the United States Food and Drug Administration (FDA) for treatment of attention-deficit/hyperactivity disorder (ADHD) in children (> 6 years old) and adults. This phase 3 open-label extension to a pivotal phase 3, double-blind trial evaluated the long-term safety and continued efficacy of viloxazine ER in adults with ADHD.
Methods: This was a multicenter, flexible-dose, open-label extension to a phase III, double-blind, placebo-controlled trial (NCT04016779).
Alzheimers Dement
November 2024
Rainwater Charitable Foundation, Fort Worth, Texas, USA.
The tauopathies are defined by pathological tau protein aggregates within a spectrum of clinically heterogeneous neurodegenerative diseases. The primary tauopathies meet the definition of rare diseases in the United States. There is no approved treatment for primary tauopathies.
View Article and Find Full Text PDFJ Med Internet Res
September 2024
Department of Information Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Background: Digital health care apps, including digital therapeutics, have the potential to increase accessibility and improve patient engagement by overcoming the limitations of traditional facility-based medical treatments. However, there are no established tools capable of quantitatively measuring long-term engagement at present.
Objective: This study aimed to evaluate an existing engagement index (EI) in a commercial health management app for long-term use and compare it with a newly developed EI.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!